Abstract: The creation of new heterocyclic scaffolds with improved pharmacological profiles has become necessary due to the growing global problem of multi-drug resistant (MDR) bacterial strains. In this investigation, a number of unique 2- (5- (3, 5-bis (trifluoromethyl) phenyl) The in vitro antibacterial potential of -1- (4-fluorophenyl) -1H-pyrazol-3-yl) -5- (alkylthio) -1, 3, 4-oxadiazole derivatives (6a–h) was carefully planned, produced, and assessed. The biologically powerful pyrazole and 1, 3, 4-oxadiazole nuclei were integrated into the molecular architecture of these hybrids, and fluorine-rich pharmacophores were then added to maximize lipophilicity and metabolic stability. The synthesis procedure produced a 1, 3-diketoester intermediate by Claisen condensation of 3, 5-bis (trifluoromethyl) acetophenone with diethyl oxalate. A combination of positional isomers (3a and 3b) was obtained via cyclization with 4-fluorophenyl hydrazine hydrochloride. The distinction of these isomers using ¹H NMR spectroscopy, where the magnetic anisotropy of the 4-fluorophenyl ring verified the shielding of the bis-trifluoromethyl phenyl protons in the major isomer 3a, was an important analytical discovery of this work. A carbohydrazide intermediate was used to convert 3a into the 1, 3, 4-oxadiazole-2-thiol scaffold. The final library was then obtained by nucleophilic S-alkylation with different alkyl halides. Several compounds have strong inhibitory activity, according to the antimicrobial screening against a panel of Gram-positive and Gram-negative microorganisms. With a Minimum Inhibitory Concentration (MIC) of 12. 5 g/mL against Pseudomonas aeruginosa—two times more effective than the reference standard, chloramphenicol (MIC 25 g/mL) —the parent thio-oxadiazole intermediate 5 stood out as a particularly strong lead. Increasing the length of the S-alkyl side chain (such as n-butyl and allyl groups) is correlated with improved antibacterial activity, according to Structure-Activity Relationship (SAR) studies. These results highlight the trifluoromethyl-substituted heterocyclic hybrids' potential as viable options for the creation of antimicrobial agents of the future. Keywords: Pyrazole, 1, 3, 4-Oxadiazole, Trifluoromethyl, Antimicrobial Activity, MIC, Isomeric Shielding, S-Alkylation. Title: Molecular Hybridization Strategies for the Synthesis of Novel Fluorinated Pyrazole-1, 3, 4-Oxadiazole S-Alkyl Hybrids: Regioselective Construction and Evaluation as Potential Antimicrobial Leads Author: Kashi Ram, Dr Narendra Singh, Teja Ram, Dr Ritika Dadhich, Babu Lal Patel International Journal of Interdisciplinary Research and Innovations ISSN 2348-1218 (print), ISSN 2348-1226 (online) Vol. 14, Issue 2, April 2026 - June 2026 Page No: 17-28 Research Publish Journals Website: www. researchpublish. com Published Date: 15-April-2026 DOI: https: //doi. org/10. 5281/zenodo. 19594781 Paper Download Link (Source) https: //www. researchpublish. com/papers/molecular-hybridization-strategies-for-the-synthesis-of-novel-fluorinated-pyrazole-134-oxadiazole-s-alkyl-hybrids-regioselective-construction-and-evaluation-as-potential-antimicrobial-leads
Ram et al. (Wed,) studied this question.